Leif Gunnar Håkansson
Directeur Général chez CanImGuide Therapeutics AB
Postes actifs de Leif Gunnar Håkansson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Directeur/Membre du Conseil | - | - |
| Directeur Général | - | - | |
| Directeur Technique/Scientifique/R&D | - | - | |
| Fondateur | - | - |
Historique de carrière de Leif Gunnar Håkansson
Anciens postes connus de Leif Gunnar Håkansson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | Corporate Officer/Principal | - | - |
| University of Lund | Corporate Officer/Principal | - | - |
Formation de Leif Gunnar Håkansson
| University of Lund | Doctorate Degree |
Statistiques
Internationale
| Suède | 4 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
- Bourse
- Insiders
- Leif Gunnar Håkansson
- Expérience
